NIT
ANAB icon

NumerixS Investment Technologies’s AnaptysBio ANAB Stock Holding History

NumerixS Investment Technologies’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,900
Closed -$220K – 996
2019
Q2 		$220K Buy
+3,900
New +$281K 0.06% 383
2018
Q4 		– Sell
-3,300
Closed -$321K – 1065
2018
Q3 		$321K Buy
+3,300
New +$274K 0.06% 419

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NumerixS Investment Technologies's ANAB Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of AnaptysBio (ANAB) in Q3 2019, closing a stake of 3,900 shares — an estimated $220K sold.

NumerixS Investment Technologies first reported a position in ANAB in Q3 2018 and held it in 2 quarters. The position peaked at $321K in Q3 2018. 119 funds tracked by Wall St. Rank hold ANAB as of Q3 2019.

  • NumerixS Investment Technologies reported no remaining AnaptysBio position as of Q3 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,900 AnaptysBio shares in Q3 2019, an estimated $220K.
  • NumerixS Investment Technologies first reported a position in AnaptysBio in Q3 2018 and held it in 2 quarters.
  • NumerixS Investment Technologies's AnaptysBio position peaked at $321K in Q3 2018.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.